Indaptus Therapeutics, Inc.

INDP

$1.16

-0.85%

2026-09-04 09:41:16 EDT+$0.00

Healthcare

Biotechnology

NASDAQ

Active Trading

Indaptus Therapeutics, Inc. is a biotechnology company operating in the pre-clinical phase, dedicated to developing a range of immunotherapeutic products for the ...

Financial Highlights of INDP

Profitability trend

Latest / TTM · 6 periods

Gross Margin

0.0%

Net Margin

0.0%

P/E Ratio

-0.17x

n/a

Debt / Equity

0.00

n/a

Current Ratio

19.48

Dividend Yield

0.0%

Understanding

TTM —

Interest coverage is weak

Financial highlights

Latest / TTM · 6 periods

Snapshot

Latest / TTM: 2026-09-04

Gross Margin

0.0%

Net Margin

0.0%

P/E Ratio

-0.17x

Debt / Equity

0.00

Profitability

Profitability table

Metric	2021	2022	2023	2024	2025	2026
Gross MarginGross profit as a percentage of revenue.	0.0%	0.0%	0.0%	0.0%	0.0%	—
Operating MarginOperating income as a percentage of revenue.	0.0%	0.0%	0.0%	0.0%	0.0%	—
Net MarginNet income as a percentage of revenue.	0.0%	0.0%	0.0%	0.0%	0.0%	—
EBITDA MarginEBITDA divided by revenue.	0.0%	0.0%	0.0%	0.0%	0.0%	—
Pre-tax MarginPre-tax profit as a percentage of revenue.	0.0%	0.0%	0.0%	0.0%	0.0%	—

Liquidity & leverage

Liquidity & leverage table

Metric	2021	2022	2023	2024	2025	2026
Current RatioCurrent assets divided by current liabilities.	8.77	7.94	5.05	1.95	1.51	—
Quick RatioLiquid assets divided by current liabilities.	8.77	7.94	5.05	1.95	1.51	—
Cash RatioCash and equivalents divided by current liabilities.	8.50	2.80	4.82	1.71	1.38	—
Debt / AssetsDebt as a share of total assets.	0.4%	0.3%	1.2%	1.1%	0.0%	—
Debt / EquityDebt compared with shareholder equity.	0.00	0.00	0.01	0.02	0.00	—

Operating efficiency

Operating efficiency table

Metric	2021	2022	2023	2024	2025	2026
Receivables TurnoverHow often receivables are collected in a year.	0.00x	0.00x	0.00x	0.00x	0.00x	—
Inventory TurnoverHow often inventory is sold in a year.	0.00x	0.00x	0.00x	0.00x	0.00x	—
Payables TurnoverHow often payables are paid in a year.	0.00x	0.00x	0.00x	0.00x	0.00x	—
Asset TurnoverRevenue generated per dollar of assets.	0.00x	0.00x	0.00x	0.00x	0.00x	—
Working Capital TurnoverRevenue generated per dollar of working capital.	0.00x	0.00x	0.00x	0.00x	0.00x	—

Valuation ratios

Valuation ratios table

Metric	2021	2022	2023	2024	2025	2026
P/E RatioPrice paid for each dollar of earnings.	-3.02x	-0.84x	-0.96x	-0.52x	-0.13x	—
P/B RatioPrice paid for each dollar of book value.	0.65x	0.49x	1.22x	2.00x	0.89x	—
P/S RatioPrice paid for each dollar of sales.	0.00x	0.00x	0.00x	0.00x	0.00x	—
P/FCF RatioPrice paid for each dollar of free cash flow.	-2.06x	-0.90x	-1.10x	-0.64x	-0.19x	—
Dividend YieldAnnual dividend divided by current share price.	0.0%	0.0%	0.0%	0.0%	0.0%	—

Upstream

Contract Research Organizations (Unnamed CROs)Contract Development & Manufacturing Organizations (Unnamed CDMOs)BeiGene, Ltd. (BeOne Medicines AG)NASDAQ:ONCMicrobiological Reagent & Raw Material Suppliers (Unnamed)

Downstream

Emory University / Winship Cancer InstituteMorristown Medical Center (Atlantic Health System)Hoag Medical Group (Newport Beach, CA)BeiGene, Ltd. (BeOne Medicines AG)NASDAQ:ONC

Proxies

CG Oncology, Inc.NASDAQ:CGON Vor Biopharma Inc.NASDAQ:VOR Agenus Inc.NASDAQ:AGEN BeOne Medicines AG (formerly BeiGene)NASDAQ:ONC

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer

No matching stocks found

Indaptus Therapeutics, Inc.

Financial Highlights of INDP

Financial highlights

Snapshot

Profitability

Liquidity & leverage

Operating efficiency

Valuation ratios

Supply Chain of INDP

Upstream

Downstream

Proxies

Financial Highlights of INDP

Financial highlights

Snapshot

Profitability

Liquidity & leverage

Operating efficiency

Valuation ratios

Supply Chain of INDP

Upstream

Downstream

Proxies